Search Results - "MIYAGISHIMA, Takuto"

Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia by Aiba, Masayuki, Shigematsu, Akio, Suzuki, Toma, Miyagishima, Takuto

“…Venetoclax (VEN) is now widely used in the treatment of acute myelogenous leukemia (AML) in elderly patients who are not eligible for intensive remission…”
Get full text

Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma by Matsukawa, Toshihiro, Suto, Keito, Kanaya, Minoru, Izumiyama, Koh, Minauchi, Koichiro, Yoshida, Shota, Oda, Hisashi, Miyagishima, Takuto, Mori, Akio, Ota, Shuichi, Hashimoto, Daigo, Teshima, Takanori

“…Diffuse large B cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin lymphoma. Emerging evidence indicates that poor nutritional status…”
Get full text

High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia by Senjo, Hajime, Onozawa, Masahiro, Hidaka, Daisuke, Yokoyama, Shota, Yamamoto, Satoshi, Tsutsumi, Yutaka, Haseyama, Yoshihito, Nagashima, Takahiro, Mori, Akio, Ota, Shuichi, Sakai, Hajime, Ishihara, Toshimichi, Miyagishima, Takuto, Kakinoki, Yasutaka, Kurosawa, Mitsutoshi, Kobayashi, Hajime, Iwasaki, Hiroshi, Hashimoto, Daigo, Kondo, Takeshi, Teshima, Takanori

“…Acute myeloid leukemia (AML) patients older than 65 years have a poor prognosis. Recently, CAR (C-reactive-protein/albumin ratio) has been actively reported as…”
Get full text

Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria by Sho, Takuya, Suda, Goki, Ogawa, Koji, Shigesawa, Taku, Suzuki, Kazuharu, Nakamura, Akihisa, Ohara, Masatsugu, Umemura, Machiko, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken, Baba, Masaru, Ito, Jun, Yamamoto, Yoshiya, Kobayashi, Tomoe, Meguro, Takashi, Saga, Akiyoshi, Miyagishima, Takuto, Terasita, Katsumi, Takagi, Tomofumi, Kamiyama, Toshiya, Taketomi, Akinobu, Sakamoto, Naoya

“…Aim This study aimed to determine the efficacy and safety of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC) who did not meet REFLECT…”
Get full text

Clinicopathological analysis of primary splenic diffuse large B‐cell lymphoma by Shimono, Joji, Miyoshi, Hiroaki, Kiyasu, Junichi, Sato, Kensaku, Kamimura, Tomohiko, Eto, Tetsuya, Miyagishima, Takuto, Nagafuji, Koji, Teshima, Takanori, Ohshima, Koichi

“…Summary Splenic infiltration is often seen in diffuse large B‐cell lymphoma (DLBCL). However, primary splenic DLBCL is rare and studies on its…”
Get full text

Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria by Sho, Takuya, Suda, Goki, Ogawa, Koji, Kimura, Megumi, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Maehara, Osamu, Ohnishi, Shunsuke, Shigesawa, Taku, Nakamura, Akihisa, Yamada, Ren, Ohara, Masatsugu, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken, Baba, Masaru, Yamamoto, Yoshiya, Suzuki, Kazuharu, Izumi, Takaaki, Meguro, Takashi, Terashita, Katsumi, Ito, Jun, Miyagishima, Takuto, Sakamoto, Naoya

“…Aim A clinical trial (IMbrave150) indicated the efficacy and safety of atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma…”
Get full text

Clinicopathological analysis of polyploid diffuse large B-cell lymphoma by Shimono, Joji, Miyoshi, Hiroaki, Kiyasu, Junichi, Kamimura, Tomohiko, Eto, Tetsuya, Miyagishima, Takuto, Nagafuji, Koji, Seto, Masao, Teshima, Takanori, Ohshima, Koichi

“…Polyploid chromosomes are those with more than two sets of homologous chromosomes. Polyploid chromosomal abnormalities are observed in various malignant…”
Get full text

A novel nutritional index “simplified CONUT” and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia by Senjo, Hajime, Onozawa, Masahiro, Hidaka, Daisuke, Yokoyama, Shota, Yamamoto, Satoshi, Tsutsumi, Yutaka, Haseyama, Yoshihito, Nagashima, Takahiro, Mori, Akio, Ota, Shuichi, Sakai, Hajime, Ishihara, Toshimichi, Miyagishima, Takuto, Kakinoki, Yasutaka, Kurosawa, Mitsutoshi, Kobayashi, Hajime, Iwasaki, Hiroshi, Hashimoto, Daigo, Kondo, Takeshi, Teshima, Takanori

“…Elderly patients aged 65 or older with acute myeloid leukemia (AML) have poor prognosis. The risk stratification based on genetic alteration has been proposed…”
Get full text

Infection with male and female Trichuris trichiura diagnosed in a non‐endemic area by Inoue, Masaki, Ishikawa, Marin, Tanaka, Sho, Zhang, Xinhan, Okada, Hiromi, Miyagishima, Takuto

“…Key Clinical Message Trichuris trichiura parasitizes only humans through fecal‐oral transmission. In non‐endemic areas, the frequency of endoscopic…”
Get full text

Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test by Kondo, Takeshi, Fujioka, Mari, Fujisawa, Shinichi, Sato, Kaori, Tsuda, Masumi, Miyagishima, Takuto, Mori, Akio, Iwasaki, Hiroshi, Kakinoki, Yasutaka, Yamamoto, Satoshi, Haseyama, Yoshihito, Ando, Seisho, Shindo, Motohiro, Ota, Shuichi, Kurosawa, Mitsutoshi, Ohba, Yusuke, Teshima, Takanori

“…Nilotinib is widely used for primary treatment of patients with chronic myelogenous leukemia (CML). We previously reported that use of an FRET-based drug…”
Get full text

Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia by Ishida, Yoji, Murai, Kazunori, Yamaguchi, Kohei, Miyagishima, Takuto, Shindo, Motohiro, Ogawa, Kazuei, Nagashima, Takahiro, Sato, Shinji, Watanabe, Reiko, Yamamoto, Satoshi, Hirose, Takayuki, Saitou, Souich, Yonezumi, Masakatsu, Kondo, Takeshi, Kato, Yuichi, Mochizuki, Noboru, Ohno, Keiko, Kishino, Satoshi, Kubo, Kohmei, Oyake, Tatsuo, Ito, Shigeki

“…Purpose Dasatinib is a novel, oral, multi-targeted kinase inhibitor of breakpoint cluster region-abelson ( BCR-ABL ) and Src family kinases. The study…”
Get full text

Feasibility of a modified search, coagulation, and clipping method with and without the use of polyglycolic acid sheets and fibrin glue for preventing delayed bleeding after gastric endoscopic submucosal dissection by Abiko, Satoshi, Oda, Soichiro, Meno, Akimitsu, Shido, Akane, Yoshida, Sonoe, Yoshikawa, Ayumu, Harada, Kazuaki, Kawagishi, Naoki, Sano, Itsuki, Oda, Hisashi, Miyagishima, Takuto

“…Methods have been developed for preventing delayed bleeding (DB) after gastric endoscopic submucosal dissection (GESD). However, none of the methods can…”
Get full text

Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy by Matsukawa, Toshihiro, Suto, Keito, Miyoshi, Hiroaki, Oshimi, Kazuo, Ohshima, Koichi, Miyagishima, Takuto

“…[TO THE EDITOR] A 79-year-old Japanese man presented with systemic papules without itch or pain. His Eastern Cooperative Oncology Group performance status was…”
Get full text

Synchronous case of follicular lymphoma and Langerhans cell sarcoma in the same lymph node by Shimono, Joji, Miyoshi, Hiroaki, Arakawa, Fumiko, Abe, Hideyuki, Miyagishima, Takuto, Akiba, Jun, Teshima, Takanori, Ohshima, Koichi

“…Langerhans cell sarcoma (LCS) is a very rare histiocytic and dendritic cell neoplasm originating from Langerhans cells. There are case reports of histiocytic…”
Get full text

Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting by Sho, Takuya, Suda, Goki, Ogawa, Koji, Kimura, Megumi, Shimazaki, Tomoe, Maehara, Osamu, Shigesawa, Taku, Suzuki, Kazuharu, Nakamura, Akihisa, Ohara, Masatsugu, Umemura, Machiko, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken, Baba, Masaru, Yamamoto, Yoshiya, Kobayashi, Tomoe, Meguro, Takashi, Saga, Akiyoshi, Miyagishima, Takuto, Yokoo, Hideki, Kamiyama, Toshiya, Taketomi, Akinobu, Sakamoto, Naoya

“…Background and Aim Lenvatinib has been recently approved as a first‐line systematic therapy for patients with advanced hepatocellular carcinoma (HCC) based on…”
Get full text

Open‐label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron by Komatsu, Yoshito, Okita, Kenji, Yuki, Satoshi, Furuhata, Tomohisa, Fukushima, Hiraku, Masuko, Hiroyuki, Kawamoto, Yasuyuki, Isobe, Hiroshi, Miyagishima, Takuto, Sasaki, Kazuaki, Nakamura, Michio, Ohsaki, Yoshinobu, Nakajima, Junta, Tateyama, Miki, Eto, Kazunori, Minami, Shinya, Yokoyama, Ryoji, Iwanaga, Ichiro, Shibuya, Hitoshi, Kudo, Mineo, Oba, Koji, Takahashi, Yasuo

“…The purpose of this study is to compare the efficacy of a single administration of dexamethasone (DEX) on day 1 against DEX administration on days 1–3 in…”
Get full text

Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies by Nakatsumi, Hiroshi, Komatsu, Yoshito, Muranaka, Tetsuhito, Yuki, Satoshi, Kawamoto, Yasuyuki, Harada, Kazuaki, Dazai, Masayoshi, Tateyama, Miki, Sasaki, Yusuke, Miyagishima, Takuto, Tsuji, Yasushi, Katagiri, Masaki, Nakamura, Michio, Sogabe, Susumu, Hatanaka, Kazuteru, Meguro, Takashi, Kobayashi, Tomoe, Ishiguro, Atsushi, Muto, Osamu, Shindo, Yoshiaki, Kotaka, Masahito, Ando, Takayuki, Takagi, Ryo, Sakamoto, Naoya, Sakata, Yu

“…BackgroundThe first-line chemotherapy for patients with RAS and BRAF wild-type metastatic colorectal cancer (mCRC) commonly involves cytotoxic regimens, such…”
Get full text

Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer by Nakano, Shintaro, Kawamoto, Yasuyuki, Yuki, Satoshi, Harada, Kazuaki, Miyagishima, Takuto, Sogabe, Susumu, Dazai, Masayoshi, Sato, Atsushi, Ishiguro, Atsushi, Nakamura, Michio, Kajiura, Shinya, Takahashi, Yasuo, Tateyama, Miki, Hatanaka, Kazuteru, Tsuji, Yasushi, Sasaki, Takahide, Shindo, Yoshiaki, Kobayashi, Tomoe, Yokota, Isao, Sakamoto, Naoya, Sakata, Yuh, Komatsu, Yoshito

“…IntroductionCombination chemotherapy with oxaliplatin, irinotecan, fluorouracil and leucovorin (FOLFIRINOX) has become one of the standard treatments for…”
Get full text

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment by Hosoda, Shunichi, Suda, Goki, Sho, Takuya, Ogawa, Koji, Kimura, Megumi, Yang, Zijian, Yoshida, Sonoe, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Maehara, Osamu, Ohnishi, Shunsuke, Nakamura, Akihisa, Yamada, Ren, Ohara, Masatsugu, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken, Baba, Masaru, Yamamoto, Yoshiya, Suzuki, Kazuharu, Izumi, Takaaki, Meguro, Takashi, Terashita, Katsumi, Ito, Jun, Miyagishima, Takuto, Sakamoto, Naoya

“…Introduction: Atezolizumab plus bevacizumab treatment is highly effective in patients with unresectable hepatocellular carcinoma (HCC). However, progressive…”
Get full text

Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients by Mori, Akio, Onozawa, Masahiro, Hidaka, Daisuke, Yokoyama, Shota, Miyajima, Toru, Yokoyama, Emi, Ogasawara, Reiki, Izumiyama, Koh, Saito, Makoto, Fujisawa, Shinichi, Ota, Shuichi, Kakinoki, Yasutaka, Tsutsumi, Yutaka, Yamamoto, Satoshi, Miyagishima, Takuto, Nagashima, Takahiro, Iwasaki, Hiroshi, Kobayashi, Hajime, Haseyama, Yoshihito, Kurosawa, Mitsutoshi, Morioka, Masanobu, Teshima, Takanori, Kondo, Takeshi

“…In this real-world clinical study, in which we determined eligibility for allogenic hematopoietic stem cell transplantation by prognostic factors and minimal…”
Get full text